Abstract
The potential for subtle pharmacological modulation of brain function through drugs selective for specific neurotransmitter receptor subtypes has prompted investigation of the roles of the different dopamine receptors in the CNS. Two clearly distinct dopamine receptor subtypes, D-1 and D-2 receptors, have been described. It has also been suggested that dopamine autoreceptors may constitute a third dopamine receptor subtype, significantly different from the D-2 receptors located on cells postsynaptic to the dopamine neurons. In recent studies, we have used neurophysiological techniques to determine how neuronal activity in the basal ganglia is affected by drugs believed selective for one or another of these receptor subtypes. These studies have raised some interesting issues with regard to the relative roles of the receptor subtypes and suggest that many factors may need to be considered in order to understand the mechanisms underlying a dopamine agonist’s net effect.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Anden, N.E., Golembiowska-Nikitin, K. and Thormstrom, U. (1982). Selective stimulation of dopamine and noradrenaline autoreceptors by B-HT 920 and B-HT 933, respectively. Naunyn-Schmiedeberg’s Arch. Pharmacol., 321, 100–104.
Arnt, J., Hyttel, J. and Perregaard, J. (1987). Dopamine D-1 receptor agonists combined with the selective D-2 agonist quinpirole facilitate the expression of oral stereotyped behaviour in rats. European J. Pharmacol., 133, 137–145.
Barone, P., Davis, T.A., Braun, A.R. and Chase, T.N. (1986). Dopaminergic mechanisms and motor function: characterization of D-1 and D-2 dopamine receptor interactions. European J. Pharmacol., 123, 109–114.
Bergstrom, D.A., Carlson, J.H., Pan, H.S. and Walters, J.R. (1987). Dopamine autoreceptor reserve on substantia nigra dopamine neurons can mask partial agonist properties of putative autoreceptor agonists. Soc. Neurosci. Abstr., 13, 490.
Bergstrom, D.A. and Walters, J.R. (1981). Neuronal responses of the globus pallidus to systemic administration of d-amphetamine: investigation of the involvement of dopamine, norepinephrine and serotonin. J. Neurosci., 1, 292–299.
Braun, A.R. and Chase, T.N. (1986). Obligatory D-1/D-2 receptor interaction in the generation of dopamine agonist related behaviors. European J. Pharmacol., 131, 301–306.
Breese, G.R. and Mueller, R.A. (1985). SCH 23390 antagonism of a D-2 dopamine agonist depends on catecholaminergic neurons. European J. Pharmacol., 113, 109–114.
Carlson, J.H., Bergstrom, D.A. and Walters, J.R. (1986). Neurophysiological evidence that D-1 dopamine receptor blockade attenuates postsynaptic but not autoreceptor-mediated effects of dopamine agonists. European J. Pharmacol., 123, 237–251.
Carlson, J.H., Bergstrom, D.A. and Walters, J.R. (1987a). Stimulation of both D-1 and D-2 dopamine receptors appears necessary for full expression of postsynaptic effects of dopamine agonists: A neurophysiological study. Brain Res., 400, 205–218.
Carlson, J.H., Bergstrom, D.A., Weick, B.G. and Walters, J.R. (1987b). Neurophysiological investigation of effects of the D-1 agonist SKF 38393 on tonic activity of substantia nigra dopamine neurons. Synapse, 1, 411–416.
Carlsson, A. (1983). Dopamine receptor agonists: Intrinsic activity vs. state of receptor. J. Neural Transm., 57, 309–315.
Gershanik, O., Heikkila, R.E. and Duvoisin, R.C. (1983). Behavioral correlations of dopamine receptor activation. Neurology, 33, 1489–1492.
Jackson, D.M. and Hashizume, M. (1986). Bromocriptine induces marked locomotor stimulation in dopamine-depleted mice when D-1 dopamine receptors are stimulated with SKF 38393. Psychopharmacol., 90, 147–149.
Meller, E., Bohmaker, K., Namba, Y., Friedhoff, A.J. and Goldstein, M. (1987). Relationship between receptor occupancy and response at striatal dopamine autoreceptors. Molecular Pharmacol., 31, 592–598.
Meller, E., Helmer-Matyjek, E., Bohmaker, K., Adler, C.H., Friedhoff, A.J. and Goldstein, M. (1986). Receptor reserve at striatal dopamine autoreceptors: Implications for selectivity of dopamine agonists. European J. Pharmacol., 123, 311–314.
Molloy, A.G. and Waddington, J.L. (1984). Dopaminergic behavior stereospecifically promoted by the D1 agonist R-SK&F 38393 and selectively blocked by the D1 antagonist SCH 23390. Psychopharmacol., 82, 409–410.
Robertson, G.S. and Robertson, H.A. (1986). Synergistic effects of D1 and D2 dopamine agonists on turning behaviour in rats. Brairt Res., 384, 387–390.
Seyfried, C.A., Greiner, H.E. and Haase, A.F. (1986). Novel dopamine agonists of the indolylbutyl ami ne type: Pre- versus postsynaptic activity in various in vivo and in vitro models. In Dopaminergic Systems and Their Regulation, (eds. G.N. Woodruff, P.J. Poat and P.J. Roberts). Macmillan Press, London, pp 375–376.
Walters, J.R., Bergstrom, D.A., Carlson, J.H., Chase, T.N. and Braun A.R. (1987). D1 dopamine receptor activation required for postsynaptic expression of D2 agonist effects. Science, 236, 719–722.
Weick, B.G. and Walters, J.R. (1987a). Effects of D-1 and D-2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D-1/D-2 coactivation induces potentiated responses. Brain Res., 405, 234–246.
Weick, B.G. and Walters, J.R. (1987b). D-1 dopamine receptor stimulation potentiates neurophysiological effects of bromocriptine in rats with lesions of the nigrostriatal dopamine pathway. Neuropharmacol., 26, 641–644.
White, F.J. (1987). D-1 dopamine receptor stimulation enables the inhibition of nucleus accumbens neurons by a D-2 receptor agonist. European J. Pharmacol., 135, 101–105.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Copyright information
© 1988 J.R. Walters, D.A. Bergstrom, J.H. Carlson, B.G. Weick and H.S. Pan
About this chapter
Cite this chapter
Walters, J.R., Bergstrom, D.A., Carlson, J.H., Weick, B.G., Pan, H.S. (1988). Electrophysiological Investigation of D-1/D-2 Receptor Interactions in the Substantia Nigra and Basal Ganglia. In: Beart, P.M., Woodruff, G.N., Jackson, D.M. (eds) Pharmacology and Functional Regulation of Dopaminergic Neurons. Satellite Symposia of the IUPHAR 10th International Congress of Pharmacology. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-10047-7_15
Download citation
DOI: https://doi.org/10.1007/978-1-349-10047-7_15
Publisher Name: Palgrave Macmillan, London
Print ISBN: 978-1-349-10049-1
Online ISBN: 978-1-349-10047-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)